Kevin T Conroy Insider Trading $EPZM Epizyme, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin T Conroy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin T Conroy. Kevin T Conroy is President & CEO in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and President and CEO in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and VP, General Counsel in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and President & CEO in EXACT SCIENCES CORP ($EXAS) and President and CEO in EXACT SCIENCES CORP ($EXAS) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Epizyme, Inc. ($EPZM) and Director in ARYA SCIENCES ACQUISITION CORP. ($ARYA).
Kevin T Conroy in Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kevin T Conroy: Director
Holdings: 11,282 shares
Current Value: $135,948
Latest Transaction: Apr 01 2021
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kevin T Conroy in Epizyme, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, ARYA, EPZM, EXAS, TWTI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 8.71 | 1,723 | 15,007 | 11,282 | 9.6 K to 11.3 K (+18.02 %) |
| Jan 05 2021 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 10.86 | 1,024 | 11,121 | 9,559 | 8.5 K to 9.6 K (+12.00 %) |
| Oct 01 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 11.93 | 933 | 11,131 | 8,535 | 7.6 K to 8.5 K (+12.27 %) |
| Jul 01 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 16.06 | 693 | 11,130 | 7,602 | 6.9 K to 7.6 K (+10.03 %) |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Apr 02 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 15.51 | 717 | 11,121 | 6,909 | 6.2 K to 6.9 K (+11.58 %) |
| Jan 03 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 24.60 | 452 | 11,119 | 6,192 | 5.7 K to 6.2 K (+7.87 %) |
| Jul 02 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 12.55 | 887 | 11,132 | 4,662 | 3.8 K to 4.7 K (+23.50 %) |
| Jun 07 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
| Jun 07 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 12.39 | 897 | 11,114 | 3,775 | 2.9 K to 3.8 K (+31.17 %) |
| Jul 02 2018 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 13.55 | 2,878 | 38,997 | 2,878 | 0 to 2.9 K |
| May 31 2018 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 17.00 | 12,500 | 212,500 | 12,500 | |
| Feb 07 2017 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 12.05 | 25,000 | 301,250 | 25,000 |
Page: 1